510(k) Report

510(k) · Cleared

Cleared

Surflo Winged Infusion Set with Needle Protection (Surshield)

K072894510(k) SpecialCleared Nov 6, 200726-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Terumo Europe N.V. · FPA Set, Administration, Intravascular

Cleared on Nov 6, 2007 as substantially equivalent to K052887 (Terumo Europe N.V., 2005) and 1 other predicate after a 26-day review. Its family tree reaches back 3 generations to 2001. 3 later devices descend from it.

Decided
Nov 6, 2007
Review
26 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K010103 (2001). 3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2014: 2 descendants cleared2010: 1 descendant clearedK010103 · Surshield Winged Infusion Set · Terumo Medical Corp. · 2001K031266 · Surshield Safety Winged Infusion Set · Terumo Corp. · 2003K052887 · Surflo Winged Infusion Set with Needle Protection (Surshield), Model SV-S23BL35VS · Terumo Europe N.V. · 2005200020052010201520202025
  1. Root · 3 generations backK010103 Surshield Winged Infusion SetTerumo Medical Corp. · 2001
  2. 2 generations backK031266 Surshield Safety Winged Infusion SetTerumo Corp. · 2003
  3. 1 generation backK052887 Surflo Winged Infusion Set with Needle Protection (Surshield), Model…Terumo Europe N.V. · 2005
  4. This deviceK072894 Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V. · 2007
  5. Descendant · cites it directly · 2 of its ownK100946 Intravscular Administration SetTerumo Europe N.V. · 2010
  6. Descendant · 2 generations on · 0 of its ownK140175 Intravascular Administration SetDelta Med Spa · 2014
  7. Descendant · cites it directly · 0 of its ownK133867 Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V. · 2014

Most influential descendants

Showing 3 of 3 · See all
  • K100946Intravscular Administration SetTerumo Europe N.V. · 2010 · cites it directly2descendants
  • K140175Intravascular Administration SetDelta Med Spa · 2014 · 2 generations on0descendants
  • K133867Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V. · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K010103Surshield Winged Infusion SetTerumo Medical Corp.2001—
−2K031266Surshield Safety Winged Infusion SetTerumo Corp.2003—
−1K052887Surflo Winged Infusion Set with Needle Protection (Surshield), Model…Terumo Europe N.V.2005—
0 (this device)K072894Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V.2007—
+1K100946Intravscular Administration SetTerumo Europe N.V.2010—
+2K140175Intravascular Administration SetDelta Med Spa2014—
+1K133867Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201420
FIG. 1 — Lineage of K072894, 2001–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052887Surflo Winged Infusion Set with Needle Protection (Surshield), Model SV-S23BL35VS
Summary page 1
…ion: Class II 2. Reason for Submission This 510k is being submitted to extend the cleared Surflo Winged Infusion Set with Needle Protection (Surshield) (K052887) product line to include a 25 Gauge needle size taking into consideration the potential issues of safety and effectiveness…
Terumo Europe N.V.2005—
*K031266Surshield Safety Winged Infusion Set
Summary page 2
…inged Infusion Set with Needle Protection (Surshield) (K052887), manufactured by Terumo Europe N.V. 2. 25G Surshield Safety Winged Infusion Set (K031266), manufactured by Teruno Medical Products (Hangzhou), China Any differences between the devices do not raise…
Terumo Corp.2003—

Also cleared against K052887: 3 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K100946Intravscular Administration SetTerumo Europe N.V.20102
K133867Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V.20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K100946 (Terumo Europe N.V., 2010) has gone furthest, with 2 descendants of its own.
  • 3 other devices also cite its predicate K052887.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Surflo Winged Infusion Set with Needle Protection (Surshield) is intended to access the peripheral vascular system, for intravenous administration of fluids and/or withdrawal of blood specimens using a syringe, luer adapter, or other compatible/appropriate devices. Additionally, after withdrawal of the needle from the patient's vein, the shield cover can be manually activated to cover the needle to minimize risk of accidental needle stick.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072894: Surflo Winged Infusion Set with Needle Protection (Surshield).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K072894

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026